Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
6-factor scoring with sector-relative rank. Updated daily.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $0.04 | $0.04 | -3.50% | 0.1M |
| 05-12 | $0.02 | $0.04 | +162.42% | 0.2M |
| 05-13 | $0.04 | $0.04 | +0.88% | 0.0M |
| 05-14 | $0.04 | $0.04 | -1.07% | 0.0M |
| 05-18 | $0.04 | $0.04 | +0.00% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
REFLECT SCIENTIFIC INC
| Metric | Q3 2024 2024-09-30 | Q3 2023 2023-09-30 |
|---|---|---|
Revenue | $1.53M | $891.38K |
Operating Income | $157.08K | $-247.72K |
Net Income | $186.95K | $-242.66K |
EPS (Diluted) | $0.00 | $0.00 |
Total Assets | $2.34M | $2.71M |
Total Liabilities | $258.55K | $631.77K |
Cash & Equivalents | $1.03M | $1.34M |
Free Cash Flow OCF − CapEx | Not available | Not available |
Shares Outstanding | 85.66M | 85.21M |
No sell-side coverage available for RSCF.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.